Fire: Created page with "{{Navbox with collapsible groups | name = Oral hypoglycemics and insulin analogs | title = Oral diabetes medication, insulins and insulin analogs, and other drugs used in diabetes (A10) | state = {{{state|expanded}}} | listclass = hlist | group1 = Insulins/insulin analogs | list1 = {{Navbox|child | group1 = ''fast-acting'' | list1= * Insulin aspart * Insulin glulisine * Insulin li..."

2024-02-04T03:01:23Z

Created page with "{{Navbox with collapsible groups | name = Oral hypoglycemics and insulin analogs | title = Oral diabetes medication, insulins and insulin analogs, and other drugs used in diabetes (A10) | state = {{{state<includeonly>|expanded</includeonly>}}} | listclass = hlist | group1 = Insulins/insulin analogs | list1 = {{Navbox|child | group1 = ''fast-acting'' | list1= * Insulin aspart * Insulin glulisine * Insulin li..."

New page

{{Navbox with collapsible groups
| name = Oral hypoglycemics and insulin analogs
| title = Oral [[diabetes medication]], [[insulin]]s and [[insulin analog]]s, and other drugs used in diabetes ([[ATC code A10|A10]])
| state = {{{state<includeonly>|expanded</includeonly>}}}
| listclass = hlist

| group1 = [[Insulin]]s/[[insulin analog]]s
| list1 = {{Navbox|child

| group1 = ''fast-acting''
| list1=
* [[Insulin aspart]]
* [[Insulin glulisine]]
* [[Insulin lispro]]

| group2 = ''short-acting''
| list2 =
* [[Regular insulin]]#

| group3 = ''long-acting''
| list3 =
* [[Insulin detemir]]#
* [[Insulin glargine]]# ([[Insulin glargine/lixisenatide|+lixisenatide]])
* [[NPH insulin]]
* [[Lente insulin]]‡
* [[Ultralente insulin]]‡

| group4 = ''ultra-long-acting''
| list4 =
* [[Insulin degludec]]# ([[Insulin degludec/insulin aspart|+insulin aspart]], [[Insulin degludec/liraglutide|+liraglutide]])
* [[Insulin icodec]]† ([[Insulin icodec/semaglutide|+semaglutide]])

| group5 = ''[[Inhalable insulin|inhalable]]''
| list5 =
* Exubera‡
* Afrezza
}}
{{PharmNavFootnote}}

| group2 = Non-insulins
| list2= {{navbox|child|
| group1 = [[Anti-diabetic medication#Sensitizers|Insulin sensitizers]]
| list1 = {{Navbox|child

| group1 = [[Biguanide]]s
| list1 =
* [[Buformin]]‡
* [[Metformin]]#
* [[Phenformin]]‡

| group2 = [[Thiazolidinedione|TZD]]s/"glitazones" ([[PPAR agonist|PPAR]])
| list2 =
* [[Ciglitazone]]§
* [[Darglitazone]]§
* [[Englitazone]]§
* [[Lobeglitazone]]
* [[Netoglitazone]]§
* [[Pioglitazone]]
* [[Rivoglitazone]]†
* [[Rosiglitazone]]
* [[Troglitazone]]‡

| group3 = [[PPAR agonist#Dual PPAR agonists|Dual PPAR agonists]]
| list3 =
* [[Aleglitazar]]†
* [[Muraglitazar]]§
* [[Saroglitazar]]
* [[Tesaglitazar]]§

| group4 = [[Amylin]] analogs and [[DACRA]]s
| list4 =
* [[Cagrilintide]]§
* [[Pramlintide]]
}}

| group2 = [[Anti-diabetic medication#Secretagogues|Secretagogues]]
| list2 = {{Navbox|child

| group1 = [[ATP-sensitive potassium channel|K+ATP]]
| list1 = {{Navbox|child
| evenodd = swap

| group1 = [[Sulfonylurea]]s
| list1 =
* ''1st generation'': [[Acetohexamide]]
* [[Carbutamide]]
* [[Chlorpropamide]]
* [[Glycyclamide]]
* [[Metahexamide]]
* [[Tolazamide]]
* [[Tolbutamide]]

* ''2nd generation'': [[Glibenclamide|Glibenclamide (glyburide)]]
* [[Glibornuride]]
* [[Glicaramide]]
* [[Gliclazide]]#
* [[Glimepiride]]
* [[Glipizide]]
* [[Gliquidone]]
* [[Glisoxepide]]
* [[Glyclopyramide]]

| group2 = [[Meglitinide]]s/"glinides"
| list2 =
* [[Mitiglinide]]
* [[Nateglinide]]
* [[Repaglinide]]

}}

| group2 = [[Glucagon-like peptide-1 receptor agonist|GLP-1 receptor agonists]]
| list2 =
* [[Albiglutide]]‡
* [[Danuglipron]]†
* [[Dulaglutide]]
* [[Exenatide]]
* [[Liraglutide]]
* [[Lixisenatide]]
* [[Orforglipron]]§
* [[Semaglutide]]
* [[Taspoglutide]]†
{{navbox|child|
group1=[[GLP1 poly-agonist peptides]]
|list1=
* [[Mazdutide]] (GLP-1/[[Glucagon receptor|GCGR]])
* [[Retatrutide]]§ (GLP-1/GIP/GCGR)
* [[Tirzepatide]] (GLP-1/GIP)
}}
| group3 = [[Dipeptidyl peptidase-4 inhibitor|DPP-4 inhibitor]]s/"gliptins"
| list3 =
* [[Alogliptin]]
* [[Anagliptin]]
* [[Evogliptin]]
* [[Garvagliptin]]
* [[Gemigliptin]]
* [[Gosogliptin]]
* [[Linagliptin]]
* [[Melogliptin]]
* [[Omarigliptin]]
* [[Saxagliptin]]
* [[Sitagliptin]]
* [[Teneligliptin]]
* [[Trelagliptin]]
* [[Vildagliptin]]
}}
|group3 = Other
|list3 = {{navbox|child
| group1 = [[Aldose reductase inhibitor]]s
| list1 =
* [[Epalrestat]]
* [[Fidarestat]]§
* [[Ranirestat]]†
* [[Tolrestat]]‡
* [[Zenarestat]]§

| group2 = [[Alpha-glucosidase inhibitor]]s
| list2 =
* [[Acarbose]]
* [[Miglitol]]
* [[Voglibose]]

| group4 = [[Gliflozin|SGLT2 inhibitors]]/"gliflozins"
| list4 =
* [[Canagliflozin]]
* [[Dapagliflozin]]
* [[Empagliflozin]]#
* [[Ertugliflozin]]
* [[Ipragliflozin]]
* [[Luseogliflozin]]
* [[Remogliflozin etabonate|Remogliflozin]]§
* [[Sergliflozin etabonate|Sergliflozin]]§
* [[Sotagliflozin]]
* [[Tofogliflozin]]†
* [[Velagliflozin]]

| group5 = Other
| list5 =
* [[Benfluorex]]‡
* [[Bromocriptine]]
* [[Imeglimin]]
}}
|group4 = [[Combination drug|Combinations]]
|list4 = {{navbox|child
|list1 =
* [[Alogliptin/metformin]]
* [[Canagliflozin/metformin]]
* [[Cagrilintide/semaglutide]]§
* [[Dapagliflozin/metformin]]
* [[Dapagliflozin/saxagliptin]]
* [[Dapagliflozin/saxagliptin/metformin]]
* [[Empagliflozin/linagliptin]]
* [[Empagliflozin/metformin]]
* [[Gemigliptin/rosuvastatin]]
* [[Glibenclamide/metformin|Glibenclamide (glyburide)/metformin]]
* [[Glimepiride/rosiglitazone]]
* [[Linagliptin/metformin]]
* [[Metformin/acarbose]]
* [[Metformin/ertugliflozin]]
* [[Metformin/evogliptin]]
* [[Metformin/gemigliptin]]
* [[Metformin/repaglinide]]
* [[Metformin/sulfonylureas]]
* [[Metformin/teneligliptin]]
* [[Phenformin/sulfonylureas]]
* [[Pioglitazone/alogliptin]]
* [[Pioglitazone/glimepiride]]
* [[Pioglitazone/metformin]]
* [[Pioglitazone/sitagliptin]]
* [[Rosiglitazone/metformin]]
* [[Saxagliptin/metformin]]
* [[Sitagliptin/dapagliflozin]]
* [[Sitagliptin/ertugliflozin]]
* [[Sitagliptin/metformin]]
* [[Simvastatin/sitagliptin|Sitagliptin/simvastatin]]
* [[Vildagliptin/metformin]]

}}
}}
{{PharmNavFootnote}}
}}
<noinclude>
{{Collapsible option}}
[[Category:Drug templates by ATC]]
</noinclude>

Template:Oral hypoglycemics and insulin analogs - Revision history